Latest Insider Transactions at Myriad Genetics Inc (MYGN)
This section provides a real-time view of insider transactions for Myriad Genetics Inc (MYGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MYRIAD GENETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MYRIAD GENETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 14
2024
|
Mark Verratti Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,076
-0.36%
|
$20,444
$19.55 P/Share
|
|
Apr 14
2024
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
940
-0.85%
|
$17,860
$19.55 P/Share
|
|
Apr 06
2024
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
581
-1.29%
|
$11,620
$20.26 P/Share
|
|
Mar 25
2024
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
363
-0.8%
|
$7,623
$21.98 P/Share
|
|
Mar 24
2024
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
45,822
-1.72%
|
$1,008,084
$22.24 P/Share
|
|
Mar 24
2024
|
Mark Verratti Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,245
-0.54%
|
$71,390
$22.24 P/Share
|
|
Mar 24
2024
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
943
-0.42%
|
$20,746
$22.24 P/Share
|
|
Mar 24
2024
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,890
-1.08%
|
$63,580
$22.24 P/Share
|
|
Mar 24
2024
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
981
-1.06%
|
$21,582
$22.24 P/Share
|
|
Mar 22
2024
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,202
-1.49%
|
$444,444
$22.24 P/Share
|
|
Mar 22
2024
|
Mark Verratti Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,648
-0.54%
|
$36,256
$22.24 P/Share
|
|
Mar 22
2024
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,405
-1.24%
|
$30,910
$22.24 P/Share
|
|
Mar 22
2024
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,685
-1.23%
|
$37,070
$22.24 P/Share
|
|
Mar 22
2024
|
Margaret Ancona EVP, Strategy & Transformation |
SELL
Payment of exercise price or tax liability
|
Direct |
730
-0.8%
|
$16,060
$22.24 P/Share
|
|
Mar 22
2024
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
363
-0.78%
|
$7,986
$22.24 P/Share
|
|
Mar 22
2024
|
Pamela Wong Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,441
-2.17%
|
$31,702
$22.24 P/Share
|
|
Mar 15
2024
|
Mark Verratti Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,686
-1.2%
|
$77,406
$21.16 P/Share
|
|
Mar 15
2024
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,322
-2.85%
|
$69,762
$21.16 P/Share
|
|
Mar 15
2024
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,306
-2.36%
|
$69,426
$21.16 P/Share
|
|
Mar 15
2024
|
Margaret Ancona EVP, Strategy & Transformation |
SELL
Payment of exercise price or tax liability
|
Direct |
1,585
-1.7%
|
$33,285
$21.16 P/Share
|
|
Mar 15
2024
|
Pamela Wong Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,568
-3.72%
|
$53,928
$21.16 P/Share
|
|
Mar 15
2024
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
30,610
-2.2%
|
$642,810
$21.16 P/Share
|
|
Mar 14
2024
|
Scott J. Leffler Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,095
+21.95%
|
-
|
|
Mar 14
2024
|
Samraat S. Raha President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
64,494
+17.65%
|
-
|
|
Mar 14
2024
|
Mark Verratti Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,631
+15.98%
|
-
|
|
Mar 14
2024
|
Dale Muzzey Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,250
+29.67%
|
-
|
|
Mar 14
2024
|
Shereen Solaiman Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,042
+42.38%
|
-
|
|
Mar 14
2024
|
Kevin Richard Haas Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,178
+20.08%
|
-
|
|
Mar 14
2024
|
Margaret Ancona EVP, Strategy & Transformation |
BUY
Grant, award, or other acquisition
|
Direct |
35,178
+27.4%
|
-
|
|
Mar 14
2024
|
Natalie Munk Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+13.83%
|
-
|
|
Mar 14
2024
|
Paul J Diaz President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
246,248
+15.04%
|
-
|
|
Mar 01
2024
|
Shereen Solaiman Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,108
-6.99%
|
$24,376
$22.18 P/Share
|
|
Feb 25
2024
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
881
-0.83%
|
$19,382
$22.72 P/Share
|
|
Feb 25
2024
|
Margaret Ancona EVP, Strategy & Transformation |
SELL
Payment of exercise price or tax liability
|
Direct |
2,231
-3.7%
|
$49,082
$22.72 P/Share
|
|
Jan 29
2024
|
Scott J. Leffler Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
117,770
+50.0%
|
-
|
|
Jan 01
2024
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
303
-0.45%
|
$5,757
$19.14 P/Share
|
|
Dec 11
2023
|
Samraat S. Raha President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
236,360
+50.0%
|
-
|
|
Dec 01
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-9.32%
|
$570,000
$19.09 P/Share
|
|
Nov 01
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-8.53%
|
$450,000
$15.69 P/Share
|
|
Oct 18
2023
|
Pamela Wong Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,309
-2.31%
|
$49,635
$15.06 P/Share
|
|
Oct 09
2023
|
Mark Verratti Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,366
-1.63%
|
$125,490
$15.01 P/Share
|
|
Oct 09
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,336
-1.71%
|
$185,040
$15.01 P/Share
|
|
Oct 09
2023
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
308
-0.45%
|
$4,620
$15.01 P/Share
|
|
Oct 09
2023
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,710
-1.59%
|
$25,650
$15.01 P/Share
|
|
Oct 09
2023
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,111
-2.6%
|
$181,665
$15.01 P/Share
|
|
Sep 26
2023
|
Mark Verratti Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,523
-1.35%
|
$52,845
$15.99 P/Share
|
|
Sep 26
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,517
-1.23%
|
$67,755
$15.99 P/Share
|
|
Sep 26
2023
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,402
-1.83%
|
$66,030
$15.99 P/Share
|
|
Sep 26
2023
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
858
-0.79%
|
$12,870
$15.99 P/Share
|
|
Sep 26
2023
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
133
-0.2%
|
$1,995
$15.99 P/Share
|